A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 6, 2008, Pages 1599-1605

  Leombruni, Paolo ^a   Pierò, Andrea ^a   Lavagnino, Luca ^a   Brustolin, Annalisa ^a   Campisi, Stefania ^a   Fassino, Secondo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Binge Eating Disorder; Fluoxetine; Medication; Obesity; Sertraline

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; ARTICLE; BINGE EATING DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; MALE; MORNING DOSAGE; NAUSEA; OBESITY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; BULIMIA NERVOSA; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 47949130407     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.06.005     Document Type: Article

References (51)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Press, Washington, DC Text Revision
2. American Psychiatric Association. Practice guideline for the treatment of patients with eating disorders, third edition. Am J Psychiatry 163 (2006) 4-54
3. Appolinario J.C., and McElroy S.L. Pharmacological approaches in the treatment of binge eating disorder. Curr Drug Targets 5 3 (2004) 301-307
4. Arnold L.M., McElroy S.L., Hudson J.I., Welge J.A., Bennet A.J., and Keck P.E. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 63 11 (2002) 1028-1033
5. Bacaltchuk J., and Hay P. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev 4 (2001) CD003391
6. Bean P., Shiltz T., Hallinan P., and Holbrook T. Self-functioning traits affecting meal compliance in eating disorders patients. Eat Weight Dis 5 (2000) 198-205
7. Beck A.T., and Steer R.A. Beck depression manual (1987), Psychological Corporation, New York
8. Brownley K.A., Berkman N.D., Sedway J.A., Lohr K.N., and Bulik C.M. Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Dis 40 (2007) 337-348
9. Bulik C.M., Sullivan P.F., and Kendler K.S. Medical and psychiatric morbidity in obese women with and without binge eating. Int J Eat Disord 32 1 (2002) 72-78
10. Bulik C.M., Brownley K.A., and Shapiro J.R. Diagnosis and management of binge eating disorder. World Psychiat 6 (2007) 142-148
11. Carter W.P., Hudson J.I., Lalonde J.K., Pindyck L., McElroy S.L., and Pope Jr. H.G. Pharmacologic treatment of binge eating disorder. Int J Eat Dis 34 (2003) S74-S88
12. Casper R.C. Binge eating: nature, assessment and treatment. J Clin Psychopharmacol 15 2 (1995) 149-150
13. Devlin M.J., Goldfein J.A., Petkova E., Jiang H., Raizman P.S., Wolk S., et al. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 13 6 (2005) 1077-1088
14. Devlin M.J., Goldfein J.A., Petkova E., Liu L., and Walsh B.T. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. Obesity 15 7 (2007) 1702-1709
15. De Zwaan M., Mitchell J.E., Seim H.C., Specker S.M., Pyle R.L., and Raymond N.C. Eating related and general psychopathology in obese females with binge eating disorder. Int J Eat Disord 15 (1994) 45-52
16. Fassino S., Leombruni P., Pierò A., Abbate-Daga G., Amianto F., Rovera G., et al. Temperament and character in obese women with and without binge eating disorder. Compr Psychiatry 43 6 (2002) 431-437
17. Fassino S., Leombruni P., Pierò A., Abbate-Daga G., and Rovera G.G. Mood, eating attitudes, and anger in obese women with and without binge eating disorder. J Psychosom Res 54 6 (2003) 559-566
18. Fassino S., Abbate-Daga G., Boggio S., Garzaro L., and Pierò A. Use of reboxetine in bulimia nervosa: a pilot study. J Psychopharmacol 18 3 (2004) 423-428
19. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Outpatient Edition (SCID-O/P, version 2.0) (1996), Biometric Research, New York State Psychiatric Institute, New York
20. Garner D.M. EDI-2. Eating disorder inventory 2. Professional manual (1991) Odessa FL
21. Gormally J., Black S., Daston S., and Rardin D. The assessment of binge eating severity among obese patients. Addict Behav 7 1 (1983) 47-59
22. Grilo C.M., and Masheb R.M. Rapid response predicts binge eating and weight loss in binge eating disorder: findings from a controlled trial of orlistat with guided self-help cognitive behavioral therapy. Behav Res Ther 45 11 (2007) 2537-2550
23. Grilo C.M., Masheb R.M., and Wilson G.T. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry 57 3 (2005) 301-309
24. Groth-Marnat G. The handbook of psychological assessment. 2nd ed. (1990), John Wiley & Sons, New York
25. Guerdjikova A.I., McElroy S.L., Kotwal R., Welge J.A., Nelson F., Lake K., et al. High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol 23 1 (2008) 1-11
26. Hudson J.I., McElroy S.L., Raymond N.C., Crow S., Keck Jr. P.E., Carter W.P., et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 155 12 (1998) 1756-1762
27. Hudson J.I., Lalonde J.K., Berry J.M., Pindyck L.J., Bulik C.M., Crow S.J., et al. Binge-eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry 63 3 (2006) 313-319
28. Jacobs-Pilipski M.J., Wilfley D.E., Crow S.J., Walsh B.T., Lilenfeld L.R., West D.S., et al. Placebo response in binge eating disorder. Int J Eat Disord 40 3 (2007) 204-211
29. Kaye W.H., Frank G.K., Bailer U.F., Henry S.E., Meltzer C.C., Price J.C., et al. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 85 1 (2005) 73-81
30. Leombruni P., Pierò A., Brustolin A., Mondelli V., Levi M., Campisi S., et al. A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters. Hum Psychopharmacol 21 3 (2006) 181-188
31. Leombruni P., Amianto F., Delsedime N., Gramaglia C., Abbate-Daga G., and Fassino S. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. Adv Ther 23 3 (2006) 481-494
32. Malhotra S., King K.H., Welge J.A., Brusman-Lovins L., and McElroy S.L. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 63 9 (2002) 802-806
33. Mannucci E., Ricca V., and Rotella C.M. Il Comportamento Alimentare nell'Obesità (2001), EDRA, Milano
34. McElroy S.L., Casuto L.S., Nelson E.B., Lake K.A., Soutullo C.A., Keck Jr. P.E., et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 157 6 (2000) 1004-1006
35. McElroy S.L., Hudson J.I., Malhorta S., Welge J.A., Nelson E.B., and Keck Jr. P.E. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiat 64 (2003) 807-813
36. Molinari E., Baruffi M., Croci M., Marchi S., and Petroni M.L. Binge eating disorder in obesity: comparison of different therapeutic strategies. Eat Weight Disord 10 3 (2005) 154-161
37. Morosin A., and Riva G. Alexithymia in a clinical sample of obese women. Psychol Rep 80 (1997) 387-394
38. Pearlstein T., Spurell E., Hohlstein L.A., Gurney V., Read J., Fuchs C., et al. A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response. Arch Women Ment Health 6 2 (2003) 147-151
39. Pi-Sunyer F.X. NHLBI Obesity Education Initiative Expert Panel on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 6 (1998) 51S-209S
40. Pope Jr. H.G., Lalonde J.K., Pindyck L.J., Walsh T., Bulik C.M., Crow S.J., et al. Binge eating disorder: a stable syndrome. Am J Psychiatry 163 12 (2006) 2181-2183
41. Ricca V., Mannucci E., Moretti S., Di Bernardo M., Zucchi T., Cabra P.L., et al. Screening for binge eating disorder in obese outpatients. Compr Psychiatry 41 2 (2000) 111-115
42. Ricca V., Mannucci E., Mezzani B., Moretti S., Di Bernardo M., Bertelli M., et al. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom 70 6 (2001) 298-306
43. Rieger E., Wilfley D.E., Stein R.I., Marino V., and Crow S.J. A comparison of quality of life in obese individuals with and without binge eating disorder. Int J Eat Disord 37 3 (2000) 234-240
44. SPSS Base 11.0. Application guide (2000), SPSS, Chicago
45. Steffen K.J., Roerig J.L., Mitchell J.E., and Uppala S. Emerging drugs for eating disorder treatment. Expert Opin Emerg Drugs 11 2 (2006) 315-336
46. Striegel-Moore R.H., Cachelin F.M., Dohm F.A., Pike K.M., Wilfley D.E., and Fairburn C.G. Comparison of binge eating disorder and bulimia nervosa in a community sample. Int J Eat Dis 29 (2001) 157-165
47. Taylor G.J., Parker J.D., Bagby R.M., and Bourke M.P. Relationship between alexithymia and psychological characteristics associated with eating disorders. J Psychosom Res 41 (1996) 561-568
48. van Hanswijck de Jonge P., Van Furth E.F., Lacey J.H., and Waller G. The prevalence of DSM-IV personality pathology among individuals with bulimia nervosa, binge eating disorder and obesity. Psychol Med 33 7 (2003) 1311-1317
49. Vaswani M., Linda F.K., and Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuro-psychopharmacol Biol Psychiatry 27 1 (2003) 85-102
50. Waters A., Hill A., and Waller G. Internal and external antecedents of binge eating episodes in a group of women with bulimia nervosa. Int J Eat Dis 29 (2001) 17-22
51. White M.A., and Grilo C.M. Psychiatric comorbidity in binge-eating disorder as a function of smoking history. J Clin Psychiatry 67 4 (2006) 594-599